ArticleExperimental and therapeutic medicine2025
Comparative analysis of rapid expansion combined with maxillary protraction therapy in patients at different growth phases: A retrospective study.
Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The best timing for treating adolescent patients with skeletal class III malocclusion is still unclear. The present study aimed to explore variations in the efficacy of rapid expansion combined with maxillary protraction therapy in patients with skeletal class III malocclusion at different growth and development stages. Clinical records of 45 patients with skeletal class III malocclusion who underwent rapid expansion combined with maxillary protraction therapy from January 2019 to June 2022 were included in the present study. Based on the cervical vertebral maturation method (CVM), the patients were retrospectively divided into three groups: Pre-pubertal (CVM stages I-II, n=15), pubertal (CVM stage III, n=15) and post-pubertal (CVM stages IV-VI, n=15). Lateral head radiographs before and after the treatment and various bone, dental and soft tissue measurements were compared between groups to assess the differences in treatment effects. The results of the intra-group comparison before and after the treatment showed that the dental and bone indicators, such as A Point-Nasion-Point B angle, sella-nasion-A point angle, sella-nasion-B point angle, mandibular plane angle, A Point-VR plane and anterior Nasal-VR plane (ANS-VR) were significantly different compared with those before treatment in all three groups of patients (P<0.05). The posterior Nasal-VR plane (PNS-VR) changed significantly in the pre-pubertal and pubertal groups (P<0.05), but there was no significant change in the post-pubertal group. The Glabella-Pronasale-Pogonion of soft tissue and Sella-Nasion-Nasion-Bs Point angle decreased significantly post-treatment in the three groups, while the Sella-Nasion-Nasion-Sn Point angle increased (P<0.05). Intergroup comparisons before and after treatment showed that there was no significant difference in the post-treatment indexes between the pre-pubertal and pubertal groups. The changes in ANS-VR and PNS-VR values before and after treatment were statistically significant between the post-pubertal and the other two groups (P<0.05). In conclusion, rapid expansion combined with maxillary protraction therapy has the best treatment effects in patients in the pre-pubertal and pubertal stages and is associated with significant skeletal effects and less alveolar response. Although the skeletal treatment effects are less favorable in patients in the post-pubertal stage with more pronounced alveolar responses, the treatment can still provide appropriate compensation for facial deformities and reduce the likelihood of orthognathic surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.